A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations: Table 1
Jamie Wilson(Princess Anne Hospital), Diana Eccles(Princess Anne Hospital), J. Louise Jones(Queen Mary University of London), Helen Hanson(University of Exeter), Nazneen Rahman(Institute of Cancer Research), Qi An(Chinese Academy of Medical Sciences & Peking Union Medical College), D. Gareth Evans(Manchester Academic Health Science Centre), Adrian C Bateman(Southampton General Hospital)
Cited by 119
Related Papers
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
MicroRNA Related Polymorphisms and Breast Cancer Risk
|PLoS ONE|2014|638
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
|Nature Genetics|2015|634
A common coding variant in CASP8 is associated with breast cancer risk
|Nature Genetics|2007|612